NCT01984983View on ClinicalTrials.gov

Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

May 31, 2015

Conditions
Venezuelan Equine Encephalitis Virus Infection
Interventions
BIOLOGICAL

Venezuelan Equine Encephalitis Virus DNA Vaccine Candidate

OTHER

0.9% saline placebo

Trial Locations (1)

92108

Accelovance, San Diego

Sponsors
All Listed Sponsors
collaborator

US Army Medical Research Institute of Infectious Diseases

FED

lead

Ichor Medical Systems Incorporated

INDUSTRY

NCT01984983 - Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers | Biotech Hunter | Biotech Hunter